CAS 943609-66-3
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 prodotti.
Vedolizumab
CAS:<p>Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of Crohn's disease and ulcerative colitis.</p>Purezza:SDS-PAGE:98.4%;SEC-HPLC:99.1%Colore e forma:LiquidPeso molecolare:146.80 kDaVedolizumab
CAS:<p>Inhibits lymphocyte adhesion to mucosal endothelium; Crohn's disease therapy</p>Purezza:Min. 95%
